1524-88-5,MFCD00079290
Catalog No.:AA006TZF

1524-88-5 | Flurandrenolide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$36.00   $25.00
- +
5mg
≥98%
in stock  
$135.00   $94.00
- +
10mg
≥98%
in stock  
$250.00   $175.00
- +
25mg
≥98%
in stock  
$580.00   $406.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA006TZF
Chemical Name:
Flurandrenolide
CAS Number:
1524-88-5
Molecular Formula:
C24H33FO6
Molecular Weight:
436.5136
MDL Number:
MFCD00079290
SMILES:
OCC(=O)[C@@]12OC(O[C@@H]1CC1C2(C)CC(O)C2C1C[C@@H](C1=CC(=O)CCC21C)F)(C)C
Properties
Properties
 
Form:
Solid  
MP:
>215°C (dec.)  
Storage:
-20 ℃;Inert atmosphere;  

Computed Properties
 
Complexity:
868  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.4  

Literature

Title: A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discovery.

Journal: Journal of biomolecular screening 20120801

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801

Title: Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal: Journal of medicinal chemistry 20110714

Title: Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.

Journal: Circulation 20110104

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Flesh-colored, rubbery nodules in a young girl.

Journal: Pediatric dermatology 20100101

Title: Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.

Journal: Journal of drugs in dermatology : JDD 20081001

Title: Linear cutaneous lupus erythematosus in the lines of Blaschko.

Journal: Pediatric dermatology 20070101

Title: Extensive keloid formation and progression after each vaccination.

Journal: Human vaccines 20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.

Journal: The Journal of dermatological treatment 20030601

Title: [Anti-inflammatory activity of a topical glucocorticoid, fludroxycortide tape in experimental animals (author's transl)].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19801001

Title: Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.

Journal: Archives of dermatology 19760801

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1524-88-5 Molecular Formula|1524-88-5 MDL|1524-88-5 SMILES|1524-88-5 Flurandrenolide
Catalog No.: AA006TZF
1524-88-5,MFCD00079290
1524-88-5 | Flurandrenolide
Pack Size: 1mg
Purity: ≥98%
in stock
$36.00 $25.00
Pack Size: 5mg
Purity: ≥98%
in stock
$135.00 $94.00
Pack Size: 10mg
Purity: ≥98%
in stock
$250.00 $175.00
Pack Size: 25mg
Purity: ≥98%
in stock
$580.00 $406.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA006TZF
Chemical Name: Flurandrenolide
CAS Number: 1524-88-5
Molecular Formula: C24H33FO6
Molecular Weight: 436.5136
MDL Number: MFCD00079290
SMILES: OCC(=O)[C@@]12OC(O[C@@H]1CC1C2(C)CC(O)C2C1C[C@@H](C1=CC(=O)CCC21C)F)(C)C
Properties
Form: Solid  
MP: >215°C (dec.)  
Storage: -20 ℃;Inert atmosphere;  
Complexity: 868  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 9  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.4  
Literature fold

Title: A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discovery.

Journal: Journal of biomolecular screening20120801

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology20111201

Title: Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer20110801

Title: Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal: Journal of medicinal chemistry20110714

Title: Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.

Journal: Circulation20110104

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Flesh-colored, rubbery nodules in a young girl.

Journal: Pediatric dermatology20100101

Title: Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.

Journal: Journal of drugs in dermatology : JDD20081001

Title: Linear cutaneous lupus erythematosus in the lines of Blaschko.

Journal: Pediatric dermatology20070101

Title: Extensive keloid formation and progression after each vaccination.

Journal: Human vaccines20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.

Journal: The Journal of dermatological treatment20030601

Title: [Anti-inflammatory activity of a topical glucocorticoid, fludroxycortide tape in experimental animals (author's transl)].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica19801001

Title: Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.

Journal: Archives of dermatology19760801

Building Blocks More >
50-35-1
50-35-1
Thalidomide
AA006UKW | MFCD00153873
24410-84-2
24410-84-2
2-Pentenoic acid, ethylester, (2E)-
AA006V70 | MFCD06204561
501008-41-9
501008-41-9
2-Methoxy-5-fluorobenzyl cyanide
AA006VX5 | MFCD00671773
228110-66-5
228110-66-5
Ethyl 4-(tert-butoxycarbonylamino) butanoate
AA006WDW | MFCD20039844
48140-35-8
48140-35-8
2-(2-Nitrophenyl)-1,3-dioxolane
AA006WZT | MFCD06209042
24051-35-2
24051-35-2
1-(3-Chlorophenyl)pyrrolidin-2-one
AA006XIS | MFCD00522616
142593-07-5
142593-07-5
Dimethyl [2,2'-bipyridine]-6,6'-dicarboxylate
AA006Y0M | MFCD11042478
505082-81-5
505082-81-5
4-(3,4-Difluorophenyl)benzoic acid
AA006YGM | MFCD03839978
141196-39-6
141196-39-6
(R)-2-(Methoxymethyl)morpholine hydrochloride
AA006YVG | MFCD16294689
49678-09-3
49678-09-3
(2E,4E)-5-(4-Nitrophenyl)penta-2,4-dienal
AA006ZBK | MFCD00011584
Submit
© 2017 AA BLOCKS, INC. All rights reserved.